PT Royal Prima Tbk (IDX:PRIM)

Market Cap	395.26B +34.5%
Revenue (ttm)	320.78B -2.7%
Net Income	-19.12B
EPS	-5.66
Shares Out	3.38B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,331,900
Open	117.00
Previous Close	117.00
Day's Range	115.00 - 118.00
52-Week Range	64.00 - 123.00
Beta	0.25
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 15, 2026

About PT Royal Prima Tbk

PT Royal Prima Tbk engages in providing hospital services and drugs in Indonesia. The company operates its hospitals under the Royal Prima Medan, Royal Prima Jambi, and RSU Royal Prima Marelan names. The company also provides health services, such as inpatient and outpatient medical services, including specialist and sub-specialist care. In addition, the company offers orthopaedic, eye, neurology, internal medicine, obstetrics and gynaecology, heart, lung, Ent-kl, urology. Further, it provides other services, including general surgery, surgical...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 2013
• Employees: 797
• Stock Exchange: Indonesia Stock Exchange
• Ticker Symbol: PRIM

Financial Performance

In 2025, PT Royal Prima Tbk's revenue was 338.91 billion, an increase of 13.21% compared to the previous year's 299.36 billion. Losses were -21.82 billion, 18.5% more than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 2, 2026

Data Sources Report a data error